These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 22916500)
1. [Construction of adenovirus carrying dual-target shRNA for Oct-4 and Survivin and its inhibitory effect on human hepatocellular carcinoma cells]. Wang D; Wang J; Li L; Chen J; Su C Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):623-31. PubMed ID: 22916500 [TBL] [Abstract][Full Text] [Related]
2. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077 [TBL] [Abstract][Full Text] [Related]
3. [Construction of the recombinant adenovirus vector bearing dual-survivin shRNA]. Gao P; Shan YX; Yang DR Zhonghua Nan Ke Xue; 2008 Apr; 14(4):324-7. PubMed ID: 18481424 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of short hairpin RNA targeting survivin gene on human ectopic endometrial cells]. Peng DX; He YL; Qiu LW Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):859-62. PubMed ID: 20423866 [TBL] [Abstract][Full Text] [Related]
5. A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect. Liu XR; Cai Y; Cao X; Wei RC; Li HL; Zhou XM; Zhang KJ; Wu S; Qian QJ; Cheng B; Huang K; Liu XY J Cell Mol Med; 2012 Jun; 16(6):1298-309. PubMed ID: 21794078 [TBL] [Abstract][Full Text] [Related]
6. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo. Yang W; Sun T; Cao J; Liu F Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA. Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241 [TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of lentiviral vectors expressing small interfering RNA targeting survivin gene on Hep-2 cell growth in vitro and in nude mice]. Yao XB; Wang XX; Zhang SQ; Yan LY; Zhu HL Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):170-2. PubMed ID: 20118014 [TBL] [Abstract][Full Text] [Related]
9. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter. Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164 [TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth. Habib R; Akhtar J; Taqi M; Yu C; Zhang C Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753 [TBL] [Abstract][Full Text] [Related]
11. Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models. Hu H; Qiu Y; Guo M; Huang Y; Fang L; Peng Z; Ji W; Xu Y; Shen S; Yan Y; Huang X; Zheng J; Su C Oncotarget; 2015 Jan; 6(2):1079-89. PubMed ID: 25473902 [TBL] [Abstract][Full Text] [Related]
12. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo. Zhang K; Li Y; Liu W; Gao X; Zhang K Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812 [TBL] [Abstract][Full Text] [Related]
13. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells. Huang Q; Zeng Y; Lin H; Zhang H; Yang D Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499 [TBL] [Abstract][Full Text] [Related]
15. Mannan-conjugated adenovirus enhanced gene therapy effects on murine hepatocellular carcinoma cells in vitro and in vivo. Liu Z; Ke F; Duan C; Lan H; Li J; Gao C; Li J; Zhong Z Bioconjug Chem; 2013 Aug; 24(8):1387-97. PubMed ID: 23937094 [TBL] [Abstract][Full Text] [Related]
16. Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter. Seo HK; Seo JB; Nam JK; Jeong KC; Shin SP; Kim IH; Lee SD; Lee SJ Oncotarget; 2014 Jul; 5(14):5615-23. PubMed ID: 25015402 [TBL] [Abstract][Full Text] [Related]
17. Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNA. Wang X; Fu Z; Zhao Y; Wu X; Shen W Eur J Cancer Prev; 2011 May; 20(3):190-8. PubMed ID: 21200325 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer. Liu C; Sun B; An N; Tan W; Cao L; Luo X; Yu Y; Feng F; Li B; Wu M; Su C; Jiang X Mol Oncol; 2011 Dec; 5(6):545-54. PubMed ID: 22032823 [TBL] [Abstract][Full Text] [Related]
19. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice. Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634 [TBL] [Abstract][Full Text] [Related]
20. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice. Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]